Provided by Tiger Trade Technology Pte. Ltd.

Odonate Therapeutics LLC

1.12
0.0000
Volume:- -
Turnover:- -
Market Cap:43.11M
PE:-0.41
High:1.12
Open:1.12
Low:1.12
Close:1.12
52wk High:28.41
52wk Low:0.8500
Shares:38.49M
Float Shares:20.63M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7114
EPS(LYR):-3.8448
ROE:-86.14%
ROA:-33.09%
PB:0.60
PE(LYR):-0.29

Loading ...

Company Profile

Company Name:
Odonate Therapeutics LLC
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.